Table 3. Summary of case series and cohort studies describing response of HIV-1/2 dual-infected patients on ART in the HAART era. Individual case reports excluded, but are discussed in the main text.
Same-day ART initiation for patients with HIV infection and tuberculosis symptoms is as effective as deferring therapy until ...
Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
Medicines that treat HIV are called antiretroviral therapy (ART). Genvoya is a combination tablet that contains the following four medicines that work together to treat HIV. Cobicistat is a “booster.” ...
Sunlenca (lenacapavir) is a medicine that was approved by the FDA in 2022 to treat HIV in combination with other HIV medicines. Sunlenca has a unique mechanism of action and is the first medicine in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results